Literature DB >> 24222144

Transumbilical defunctioning ileostomy: A new approach for patients at risks of anastomotic leakage after laparoscopic low anterior resection.

Ken Eto1, Nobuo Omura, Koichiro Haruki, Yoshiko Uno, Masahisa Ohkuma, Shintaro Nakajima, Tadashi Anan, Makoto Kosuge, Tetsuji Fujita, Katsuhiro Ishida, Katsuhiko Yanaga.   

Abstract

BACKGROUND: The use of a protective defunctioning stoma in rectal cancer surgery has been reported to reduce the rates of reoperation for anastomotic leakage, as well as mortality after surgery. However, a protective defunctioning stoma is not often used in cases other than low rectal cancer because of the need for stoma closure later, and hesitation by patients to have a stoma. We outline a novel and patient-friendly procedure with an excellent cosmetic outcome. This procedure uses the umbilical fossa for placement of a defunctioning ileostomy followed by a simple umbilicoplasty for ileostomy closure. PATIENTS AND METHODS: This study included a total of 20 patients with low rectal cancer who underwent a laparoscopic low anterior resection with defunctioning ileostomy (10 cases with a conventional ileostomy in the right iliac fossa before March 2012, and 10 subsequent cases with ileostomy at the umbilicus) at the Jikei University Hospital in Tokyo from August 2011 to January 2013. The clinical characteristics of the two groups were compared: operative time, blood loss, length of hospital stay and postoperative complications of the initial surgery, as well as the stoma closure procedure.
RESULTS: There were no differences between the groups in the median operative time for initial surgery (248 min vs. 344 min), median blood loss during initial surgery (0 ml vs. 115 ml), and median hospital stay after initial surgery (13 days vs. 16 days). Complication rates after the initial surgery were similar. There were no differences between the groups in median operative time for stoma closure (99 min vs. 102 min), median blood loss during stoma closure (7.5 ml vs. 10 ml), and median hospital stay after stoma closure (8 days in both groups). Complications after stoma closure such as wound infection and intestinal obstruction were comparable. Thus, no significant differences in any factor were found between the two groups.
CONCLUSION: The transumbilical protective defunctioning stoma is a novel solution to anastomotic leakage after laparoscopic rectal cancer surgery, with patient-friendliness as compared to conventional procedures in light of the cosmetic outcome.

Entities:  

Keywords:  Defunctioning ileostomy; laparoscopic surgery; low anterior resection

Mesh:

Year:  2013        PMID: 24222144

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

Review 1.  Systematic review and meta-analysis of incisional hernia post-reversal of ileostomy.

Authors:  F De Haes; N L Bullen; G A Antoniou; N J Smart; S A Antoniou
Journal:  Hernia       Date:  2019-05-09       Impact factor: 4.739

2.  Temporary Diverting Ileostomy via the Umbilicus: a Small Case Series.

Authors:  C D Mushaya; Raaj Chandra; Wendy Sansom; James Keck
Journal:  Int Surg       Date:  2015-03

3.  Preliminary experience with umbilical stoma in transumbilical single-port colorectal surgery.

Authors:  A d'Alessandro; N Kari; A Alameh; N Pasquier; A Tarhini; B Vinson Bonnet; R Noun; E Chouillard
Journal:  Tech Coloproctol       Date:  2018-03-06       Impact factor: 3.781

4.  Safety and Feasibility of Umbilical Diverting Loop Ileostomy for Patients with Rectal Tumor.

Authors:  Masaaki Miyo; Ichiro Takemasa; Taishi Hata; Tsunekazu Mizushima; Yuichiro Doki; Masaki Mori
Journal:  World J Surg       Date:  2017-12       Impact factor: 3.352

5.  Defunctioning Ileostomy to Prevent the Anastomotic Leakage in Colorectal Surgery. The State of the Art of the Different Available Types.

Authors:  Diego Coletta; Cristina De Padua; Immacolata Iannone; Antonella Puzzovio; Paola Antonella Greco; Alberto Patriti; Filippo La Torre
Journal:  Front Surg       Date:  2022-04-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.